Session Type
Meeting
Search Results for Readmission
Abstract Number: 476
Hospital Medicine 2020, Virtual Competition
Background: COPD is the third leading cause of death and hospital readmissions. Inpatient care for patients with COPD exacerbations varies widely across the US which can lead to patients failing to receive recommended evaluation, treatment, education, and follow-up to reduce the likelihood of recurrent exacerbations and unnecessary acute care utilization. In an effort to innovate […]
Abstract Number: 597
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: A 76 year-old male with a history of diverticulitis, T2DM, HTN, persistent atrial fibrillation and compensated alcoholic cirrhosis presented for recurrent gastrointestinal bleeding (GIB). He initially presented to an outside hospital six months prior for shortness of breath and found to be anemic requiring 4 units of packed red blood cells (PRBCs). Since […]
Abstract Number: B23
SHM Converge 2022
Background: The Centers for Medicare & Medicaid Services (CMS) uses a five‐star quality rating system to measure Medicare beneficiaries’ experience with their health care system. Unplanned readmission rates serve as a marker of the effectiveness and safety of its transitional care process and carry significant weight in determining a hospital’s overall rating. Our institution, an […]
Abstract Number: C16
SHM Converge 2022
Background: Effective communication at hospital discharge between inpatient and outpatient providers is critical to improving transitions of care and reducing hospital readmissions. A key part of transitions communication is the hospital discharge summary (DCS). Prior studies show that DCSs are often not available to primary care providers (PCPs) at the time of hospital follow-up and […]
Abstract Number: E14
SHM Converge 2022
Background: Readmissions are costly to the healthcare system have been associated with low patient satisfaction scores, longer length of stay, and higher mortality. Identifying and addressing patient needs at the time of transitioning care from the inpatient to outpatient setting has the potential to reduce readmission rates. The purpose of our project was to develop […]
Abstract Number: G16
SHM Converge 2022
Background: Hospital clinicians may identify the presence of a patient’s comorbid conditions, overall severity of illness, and clinical status at discharge as risk factors for readmission after COVID-19 hospitalization. Objective data are lacking to support reliance on these factors for discharge decision-making. Objectives included examination of risk factors for readmission to hospital after COVID-19 hospitalization […]
Abstract Number: H16
SHM Converge 2022
Background: Up to 45% of Americans do not fill prescriptions because of cost. Medication non-adherence annually leads to $100-$300B in excess morbidity and mortality. To better inform medication cost effects on a potentially vulnerable patient population, our primary aim was to measure annual patient out-of-pocket outpatient medication cost for patients without prescription drug insurance coverage […]
Abstract Number: L12
SHM Converge 2022
Background: An estimated 1 in 5 patients are at risk for being readmitted to the hospital within 30 days of discharge. Readmissions put a large financial strain on the United States healthcare system and increase risk for poor patient care outcomes. The Centers for Medicare/Medicaid Services publicly report readmission data and have financial penalties for […]
Abstract Number: O16
SHM Converge 2022
Background: Pulmonary B-lines are a highly sensitive sonographic sign of pulmonary edema in patients with Acute Decompensated Heart Failure (ADHF) (3). When found prior to discharge, this finding has been shown to accurately predict re-admission and mortality on short term follow up (4,5,6). Inferior vena cava (IVC) diameter and collapsibility can be used as a […]
Abstract Number: P10
SHM Converge 2022
Background: Cancer patients are at risk of higher readmission rates after hospitalization, which has been associated with increased comorbidity and mortality. Development of acute kidney injury (AKI) is associated with worse clinical outcomes. In the setting of the COVID-19 pandemic, we aim to look at the 30-day readmission rate in our institution’s cancer patients with […]